Halper Sadeh LLC is investigating whether certain officers and directors of BellRing Brands, Inc. breached their fiduciary duties to shareholders. Long-term BellRing stockholders may seek corporate governance reforms, financial incentives, or other relief. The law firm offers to handle cases on a contingent fee basis, meaning no upfront legal costs for shareholders. Shareholders are urged to act quickly as there may be limited time to enforce their rights, potentially improving company oversight and shareholder value.
The investigation into BellRing Brands, Inc. insiders is a key topic for shareholders. For readers following the Consumer Staples sector, here is Pluang's market snapshot as of Oct 13, 2026 22:21 WIB: Of 57 priced US stocks, 20 rose and 35 fell. Notable movers include ADM at USD 82.36 with a 1-day change of +2.41% and 100% buy order activity, DAR at USD 62.47 with a 1-day change of +2.31%, and ELF at USD 107.56 with a 1-day change of -2.16%.
Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...
Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...
State Street is set to report its Q3 2026 earnings with forecasts showing a 31.3% increase in earnings and 14% revenue growth, driven by strong net interest income and service fees. Despite record assets under management, higher operating and technol...
Restaurant Technologies, Inc. (RTI) released its 2026 Impact Report highlighting significant progress in sustainability and operational efficiency. In 2025, RTI recycled 393 million pounds of used cooking oil and delivered 719.4 million pounds of fre...
Over 60 companies are actively developing more than 65 medical marijuana therapies targeting conditions like chronic pain, neurological disorders, and cancer symptoms. Key drugs such as ZYN-002 and CardiolRx are in late-stage trials, with others in e...
